| Issue |
Section |
Title |
File |
| Vol 16, No 1 (2019) |
Articles |
The role of ß2-adrenergic receptor gene polymorphisms in the pharmacological response to bronchial asthma therapy |
(Rus)
|
| Vol 15, No 6 (2018) |
Articles |
The modern view of the role of innate and adaptive immunity in bronchial asthma |
|
| Vol 15, No 4 (2018) |
Articles |
Federal Clinical Recommendations. Allergic rhinitis |
|
| Vol 15, No 4 (2018) |
Articles |
Class of leukotriene drugs in treatment of allergic rhinitis [Consensus document LIRA Leukotrienes and Allergic Rhinitis (LIRA, Leukotrienes Impact on Rhinitis Allergic)] |
|
| Vol 15, No 3 (2018) |
Articles |
Monoclonal antibodies in the treatment of bronchial asthma |
|
| Vol 15, No 1 (2018) |
Articles |
Bronchial asthma in combination with chronic rhinosinusitis with nasal polyps: epidemiology, prevalence and peculiarities of their relationship |
|
| Vol 15, No 1 (2018) |
Articles |
The efficiency of hypoallergenic space created with LG Puricare™ air purifier in the complex therapy of seasonal and perennial allergic rhinitis and bronchial asthma |
|
| Vol 14, No 4-5 (2017) |
Articles |
ACTUAL CONCEPTION OF ALLERGEN-SPECIFIC IMMUNOTHERAPY MECHANISMS, POTENTIAL BIOMARKERS OF EFFICACY AND WAYS OF ENHANCEMENT |
|
| Vol 14, No 4-5 (2017) |
Articles |
THE DIAGNOSTIC SIGNIFICANCE OF IMMUNOLOGICAL PARAMETERS OF THE PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS |
|
| Vol 14, No 4-5 (2017) |
Articles |
THE PLACE OF ANTILEUKOTRIENE MEDICATIONS IN ANTIINFLAMMATORY THERAPY OF BRONCHIAL ASTHMA |
|
| Vol 14, No 2 (2017) |
Articles |
Clinical contraindications to allergen immunotherapy |
|
| Vol 13, No 4-5 (2016) |
Articles |
FEDERAL CLINICAL RECOMMENDATIONS. ALLERGEN-SPECIFIC IMMUNOTHERAPY |
|
| Vol 12, No 3 (2015) |
Articles |
Allergic rhinitis and allergic conjunctivitis: one disease - two clinical forms |
|
| Vol 12, No 2 (2015) |
Articles |
Changing the basic treatment as a way to achieve asthma control |
|
| Vol 11, No 5 (2014) |
Articles |
BRONCHOLITIC THERAPY IN BRONCHIAL ASTHMA: PROPER CHOICE |
|
| Vol 8, No 2 (2011) |
Articles |
ALGORITHM OF ASSESSMENT OF ASTHMA CONTROL |
|
| Vol 8, No 2 (2011) |
Articles |
ТREATMENT AND PREVENTIVE ACTION OF NASAL SPRAY NAZAVAL IN THE ALLERGIC RHINITIS PATIENTS. CLINICAL RESEARCHES REVIEW |
|
| Vol 8, No 1 (2011) |
Articles |
Farmakoekonomicheskiy analizprimeneniya beroduala n v lecheniiobostreniya bronkhial'noy astmy |
|
| Vol 8, No 1 (2011) |
Articles |
Allergicheskiy kon\"yunktivit:sovremennyy vzglyad na aktual'nuyuproblemu |
|
| Vol 7, No 6 (2010) |
Articles |
SAFETY OF INTRANASAL CORTICOSTEROIDS |
|
| Vol 6, No 3 (2009) |
Articles |
Efficacy of allergen-specific immunotherapy with «Phostal» in seasonal allergic rhinoconjunctivitis |
|
| Vol 6, No 3 (2009) |
Articles |
Has the first generation of antihistamines any advantages? |
|
| Vol 16, No 2 (2019) |
Articles |
The response variability of the asthma patients to the standard pharmacotherapy |
(Rus)
|
| Vol 16, No 2 (2019) |
Articles |
Diagnostic and treatment algorithm for different phenotypes of chronic rhinosinusitis with nasal polyps |
(Rus)
|
| Vol 16, No 3 (2019) |
Articles |
Tiotropium bromide: additional options for the treatment of bronchial asthma |
(Rus)
|
| Vol 17, No 1 (2020) |
Articles |
2019 ARIA: care pathways for allergic rhinitis in Russia |
(Rus)
|
| Vol 17, No 1 (2020) |
Articles |
Polypous rhinosinusitis in combination with bronchial asthma: clinical features and cellular characteristics of local and systemic inflammation |
(Eng)
|
| Vol 17, No 3 (2020) |
Reviews |
Non-steroidal anti-inflammatory drugs (NSAIDs) – exacerbated respiratory disease: epidemiology, pathogenesis, clinical findings and management |
(Rus)
|
| Vol 17, No 3 (2020) |
Help to the practitioner |
Efficacy and safety of the antileukotriene drugs: relevant data. RAACI experts conclusion |
(Rus)
|
| Vol 18, No 1 (2021) |
Reviews |
Dupilumab: new opportunities for the treatment of asthma and chronic rhinosinusitis with nasal polyps |
(Rus)
(Eng)
|
| Vol 18, No 1 (2021) |
Letters to the editor |
Chronic urticaria in theory and practice. Experience of UCARE-centers for clinicians |
(Rus)
(Eng)
|
| Vol 18, No 3 (2021) |
Clinical practice guidelines |
Vaccination of patients with allergic disease against novel coronavirus infection: position paper of the Russian Association of Allergology and Clinical Immunology |
(Rus)
|
| Vol 18, No 4 (2021) |
Clinical practice guidelines |
Asthma |
(Rus)
|
| Vol 19, No 1 (2022) |
Clinical practice guidelines |
Allergic rhinitis |
(Rus)
|
| Vol 19, No 2 (2022) |
Reviews |
Allergen-specific immunotherapy and real-world evidence |
(Rus)
|
| Vol 19, No 2 (2022) |
Original studies |
Omalizumab in the severe exacerbations of seasonal allergic rhinitis |
(Rus)
(Eng)
|
| Vol 19, No 2 (2022) |
Reviews |
Combination therapy of allergic rhinitis: efficacy, safety and impact on quality of life |
(Rus)
|
| Vol 19, No 3 (2022) |
Reviews |
Molecular allergology place in allergen-specific immunotherapy |
(Rus)
|
| Vol 20, No 2 (2023) |
Reviews |
Searching for predictive biomarkers of allergen-specific immunotherapy efficacy based on modern concepts of its mechanisms |
(Rus)
(Eng)
|
| Vol 20, No 2 (2023) |
Clinical practice guidelines |
Leukotriene receptor antagonists in the treatment of bronchial asthma: Consensus agreement “Bronchial Asthma and LEukoTriene receptor antagonists (BALET)” |
(Rus)
|
| Vol 21, No 1 (2024) |
Short communications |
Potential of the domestic biosimile omalizumab in achievement of control in patients with severe asthma: short communication |
(Rus)
|
| Vol 22, No 1 (2025) |
Case reports |
Possibilities of achieving control of allergic rhinitis in a patient with skin sensitization and continued contact with pets |
(Rus)
|
